Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. - Quinn CM; Rajarajan P; Gill AJ; Kopinsky H; Wolf AB; de Camargo CS; Lamb J; Bacon TE; Murray JC; Probasco JC; Galetta KM; Kantor D; et al. (Neurology, 2024)